本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
BENRALIZUMAB
英文名:
Cas号:1044511-01-4
Cas号:1044511-01-4
检测信息查询
货号 | 规格 | 货期 | 库存 | 价格 | 会员价 | 订购 |
1308132500-1mg | 0 | ¥25000 | 请登录 |
别 名 | |
Cas号 | 1044511-01-4 |
M D L | |
分子式 | |
分子量 | |
产品参数 | Description
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma[1]. IC50 & Target IL-5Rα[1] Storage Please store the product under the recommended conditions in the Certificate of Analysis. References [1]. Menzies-Gow A, et al. Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial. ERJ Open Res. 2019 Sep 25;5(3). pii: 00009-2019. |
性状 | Benralizumab (MEDI-563) 是一种白介素 5 受体 α (IL-5Rα) 定向的溶细胞单克隆抗体,通过增强抗体依赖性细胞介导的细胞毒性诱导嗜酸性粒细胞直接,快速和几乎完全耗尽。Benralizumab 可用于严重的嗜酸性哮喘。 |
贮存 |
- Abatacept 332348-12-6
- Obinutuzumab
- Reslizumab 241473-69-8
- 那他珠单抗 189261-10-7
- BENRALIZUMAB 1044511-01-4
- Dupilumab 1190264-60-8
- 重组人FGF-ACIDIC
- Recombinant Human Amphiregulin
- Recombinant Human B cell Activating Factor/TNFSF13B